2,000 Shares in The Clorox Company (NYSE:CLX) Purchased by Kelly Financial Services LLC

Kelly Financial Services LLC acquired a new stake in The Clorox Company (NYSE:CLX) in the fourth quarter, HoldingsChannel.com reports. The fund acquired 2,000 shares of the company’s stock, valued at approximately $325,000.

A number of other institutional investors have also bought and sold shares of CLX. Brooklyn Investment Group raised its holdings in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares during the period. Prospera Private Wealth LLC purchased a new position in Clorox during the third quarter worth about $27,000. Continuum Advisory LLC raised its stake in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the period. Quarry LP boosted its holdings in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the last quarter. Finally, Carolina Wealth Advisors LLC acquired a new stake in shares of Clorox during the 3rd quarter worth approximately $48,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Performance

NYSE:CLX opened at $160.31 on Friday. The company has a market cap of $19.84 billion, a price-to-earnings ratio of 55.86, a price-to-earnings-growth ratio of 2.90 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a fifty day simple moving average of $164.25 and a two-hundred day simple moving average of $156.38.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. Clorox’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.49 EPS. As a group, equities analysts anticipate that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.04%. Clorox’s dividend payout ratio is currently 170.04%.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of recent analyst reports. DA Davidson upped their price objective on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and upped their price target for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. JPMorgan Chase & Co. raised their price objective on Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a research report on Thursday. Barclays decreased their target price on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research report on Friday. Finally, Wells Fargo & Company upgraded shares of Clorox from an “underweight” rating to an “equal weight” rating and lifted their price target for the company from $155.00 to $157.00 in a research report on Tuesday, January 7th. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $156.54.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.